Cargando…
Biomarker expression and survival in patients with non-small cell lung cancer receiving adjuvant chemotherapy in Denmark
INTRODUCTION: Programmed cell death ligand-1 (PD-L1) expression may help identify patients with non-small cell lung cancer (NSCLC) who would benefit from immunotherapy. We assessed PD-L1 expression, and epidermal growth factor receptor (EGFR) and V-Ki-Ras2 Kirsten rat sarcoma (KRAS) mutations in NSC...
Autores principales: | Dalvi, Tapashi, Nørgaard, Mette, Fryzek, Jon P., Movva, Naimisha, Pedersen, Lars, Pham Hansen, Hanh, Walker, Jill, Midha, Anita, Shire, Norah, Boothman, Anne-Marie, Rigas, James, Mellemgaard, Anders, Rasmussen, Torben R., Hamilton-Dutoit, Stephen, Cronin-Fenton, Deirdre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10089313/ https://www.ncbi.nlm.nih.gov/pubmed/37040387 http://dx.doi.org/10.1371/journal.pone.0284037 |
Ejemplares similares
-
PD-L1 expression, EGFR and KRAS mutations and survival among stage III unresected non-small cell lung cancer patients: a Danish cohort study
por: Cronin-Fenton, Deirdre, et al.
Publicado: (2021) -
Interferon gamma expression and mortality in unselected cohorts of urothelial bladder cancer patients
por: Gillezeau, Christina, et al.
Publicado: (2022) -
Pancreatic cancer survival in central and northern Denmark from 1998 through 2009: a population-based cohort study
por: Cronin-Fenton, Deirdre P, et al.
Publicado: (2011) -
A Molecular Epidemiological Analysis Of Programmed Cell Death Ligand-1 (PD-L1) Protein Expression, Mutations And Survival In Non-Small Cell Lung Cancer
por: Schabath, Matthew B, et al.
Publicado: (2019) -
Systematic Literature Review of Respiratory Syncytial Virus Laboratory Testing Practices and Incidence in United States Infants and Children <5 Years of Age
por: Movva, Naimisha, et al.
Publicado: (2022)